• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, June 25, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

In the Global South less than one-third of high blood pressure patients treated

Bioengineer by Bioengineer
July 19, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

International research team with Göttingen and Heidelberg participation finds inadequate care

IMAGE

Credit: Heidelberg University

Healthcare in low- and middle-income countries is poorly prepared for the increasing number of high blood pressure (ie hypertension) disorders. More than two-thirds of all people affected go without treatment. Researchers led by the Harvard T.H. Chan School of Public Health, the University of Göttingen and the Medical Faculty of Heidelberg have discovered this. The study appeared in The Lancet.

The research team analysed the healthcare of hypertension in 44 countries of the Global South. Using a model known as “cascade methodology”, they determined how well the health systems of the various countries are adapted. This method works like a stepped waterfall: a cascade of data shows step-by-step where patients are lost from health systems. First, the researchers determined how many people suffer from high blood pressure. Based on this, they determined how many of those patients were examined, diagnosed and treated each time. Finally, they analysed how many patients successfully controlled the disease with medication.

“Hypertension is already most prevalent in regions belonging to the Global South, particularly sub-Saharan Africa, as well as Central and South Asia,” says Pascal Geldsetzer, postdoctoral research fellow at Harvard T.H. Chan School of Public Health and first author of the study. “Our study shows not only that care for hypertension in these countries is severely inadequate, but also where exactly patients are being lost in the treatment system.”

The results: less than half of those affected are diagnosed with high blood pressure. Only 30 percent of these patients are treated and only one tenth have the disease under control. “High blood pressure can be treated relatively well and cheaply,” says Sebastian Vollmer, Professor of Development Economics at the University of Göttingen. “Undiagnosed or untreated hypertension, on the other hand, is a considerable risk for the people affected and can lead to significant complications, including death.” Till Bärnighausen, Professor of Global Health at Heidelberg University Hospital and Medical Faculty of Heidelberg, adds: “High blood pressure is already one of the major widespread diseases in the Global South and is becoming increasingly common as the populations in these countries age. This study provides important insights for policy-makers about where in the treatment chain for hypertension the greatest problems currently lie.”

In order to improve the health systems of the countries concerned, the authors look at what worked in health systems that are managing to provide care. Costa Rica, Bangladesh, Brazil, Ecuador, Kyrgyzstan and Peru are good examples.

###

The analysis was carried out with the help of STEPS data from the World Health Organisation.

Original publication: Pascal Geldsetzer et al. The state of hypertension care in 44 low- and middle-income countries: a cross-sectional study of individual-level nationally representative data from 1.1 million adults. The Lancet (2019). Doi: 10.1016/S0140-6736(19)30955-9

Contact:

Dr Pascal Geldsetzer

Department of Global Health and Population

Harvard T.H. Chan School of Public Health

665 Huntington Ave, Boston, MA 02115, USA

Tel: +1 415 694 8503

Email: [email protected]

Professor Sebastian Vollmer

University of Göttingen

Centre for Modern Indian Studies (CeMIS)

Waldweg 26, Altbau, 37073 Göttingen

Tel: +49 (0)160 6152989

Email: [email protected]

Professor Till Bärnighausen

Alexander von Humboldt University Professor

Director, Heidelberg Institute of Global Health

Heidelberg University Hospital and the Medical Faculty of Heidelberg

Im Neuenheimer Feld 130.3 | D-69120 Heidelberg

Tel: +49 (0) 6221 56-5637

Email: [email protected]

Media Contact
Melissa Sollich
[email protected]

Original Source

https://www.uni-goettingen.de/en/3240.html?id=5529

Related Journal Article

http://dx.doi.org/10.1016/S0140-6736(19)30955-9

Tags: CardiologyDisease in the Developing WorldHealth CareHealth Care Systems/ServicesInsuranceMedical/Scientific EthicsMedicine/HealthMortality/LongevityStroke
Share12Tweet8Share2ShareShareShare2

Related Posts

Tracking Lanthanide-Labeled Microplastics in Plants

June 25, 2026

Neural Design Enables Zero-Shot Drug-Binding Proteins

June 25, 2026

Genomic Insights into Human Skin Fungi Diversity

June 25, 2026

Chiral Laser Gyroscopes Surpass Lock-In Limit

June 25, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.